Cetirizina [Spanish] en es it fr

Cetirizina [Spanish] Brand names, Cetirizina [Spanish] Analogs

Cetirizina [Spanish] Brand Names Mixture

  • No information avaliable

Cetirizina [Spanish] Chemical_Formula


Cetirizina [Spanish] RX_link


Cetirizina [Spanish] fda sheet

Cetirizina_[Spanish] FDA

Cetirizina [Spanish] msds (material safety sheet)

Cetirizina [Spanish] Synthesis Reference

E. Baltes et al., U.S. Pat. 4,525,358 (1985)

Cetirizina [Spanish] Molecular Weight

388.888 g/mol

Cetirizina [Spanish] Melting Point


Cetirizina [Spanish] H2O Solubility

101 mg/L

Cetirizina [Spanish] State


Cetirizina [Spanish] LogP


Cetirizina [Spanish] Dosage Forms


Cetirizina [Spanish] Indication

For the relief of symptoms associated with seasonal allergic rhinitis, perennial allergic rhinitis and the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria

Cetirizina [Spanish] Pharmacology

Cetirizine, the active metabolite of the piperazine H1-receptor antagonist hydroxyzine, is used to treat chronic idiopathic urticaria, perennial allergic rhinitis, seasonal allergic rhinitis, allergic asthma, physical urticaria, and atopic dermatitis.

Cetirizina [Spanish] Absorption

mean peak plasma concentration (Cmax) of 114 ng/mL at a time (Tmax) of 2.2 hours postdose was observed for cetirizine

Cetirizina [Spanish] side effects and Toxicity

Somnolence (sleepiness or unusual drowsiness), restlessness, irritability

Cetirizina [Spanish] Patient Information

Cetirizina [Spanish] Organisms Affected

Humans and other mammals